Early-Stage

Groupe PARIMA supports early‑stage projects by building technical readiness for clinical manufacturing and scientifical decision‑making.

earlystage - banner
Early development support

Keeping pace with early development

Groupe PARIMA supports early-stage programs through product development, submission, and clinical lots manufacturing. We help small-molecule, non-sterile products move from laboratory scale into phase‑appropriate GMP production, with the documentation, methods, and controls required to support the next stages.

Guide early-stage with precision

We combine product development expertise, direct access to scientific teams, and operational flexibility to enable efficient early clinical execution.

Move into GMP with confidence

Phase‑appropriate GMP clinical manufacturing, supported by robust documentation, traceability, and operational discipline.

Build the right technical foundation

Establish development and method activities that generate reliable data and support early clinical manufacturing and regulatory expectations.

Plan the next steps With Efficiency

Address early‑stage development and clinical supply needs while establishing technical choices that support future progression.

One site, faster progression

Early‑stage programs require a CDMO that combines rapid execution with strong quality oversight. Groupe PARIMA’s one-site model connects scientific teams, in-house analytical support, and GMP manufacturing, helping you maintain continuity, strengthen early documentation, and reduce risks.

01
direct access to scientific teams

Direct access to scientific teams

Work directly with formulation, analytical, and manufacturing experts to support development activities, technical decision‑making, and preparation for clinical lots and submission.

02
Integrated analytical support

Integrated analytical support

In‑house analytical development and testing generate reliable data to support R&D activities, clinical batch release, and submission‑ready documentation at an early stage.

03
flexibility for early stage reality

Flexibility for early-stage reality

Our operations adapt to small‑scale batches and evolving early‑stage requirements, supporting R&D activities and clinical lot manufacturing as programs mature toward submission.

04
Pratical early stage progression

Practical early-stage progression

We support development and early clinical manufacturing while building documentation, methods, and packaging that facilitate regulatory submission and next‑stage advancement.

Our Services

We take a flexible, phase‑appropriate approach that supports R&D activities, GMP clinical manufacturing, and the technical documentation required for early submissions.

01
Product development icon
Product Development

Manufacturing-ready development that reduces rework later, with decisions that scale as requirements increase.

02
Analytical services icon
Analytical Services

Clear data for decision-making stability plans, and confident release as your program progresses.

03
icn_Manufacturing_white
Manufacturing & Packaging

Consistent execution designed for predictable release and routine supply, with controlled changes over time.

We take a practical approach to early stage, supporting development and clinical lots with the right level of technical rigor.

Resources

Explore resources that clarify early‑stage development and clinical lot requirements, to the practical steps that prepare projects for regulatory submission.

White papers
2026/07/06
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
White papers
2026/07/03
How Early API Characterization Can Reduce Formulation and Scale-up Risks
White papers
2026/07/06
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
White papers
2026/07/03
How Early API Characterization Can Reduce Formulation and Scale-up Risks

Contact us

Discuss your early-stage project

Tell us where your product stands, and our team can help you define the next development and clinical steps.